ChemicalBook CAS DataBase List 3-Morpholino-1-(4-(2-oxopiperidin-1-yl)phenyl)-5,6-dihydropyridin-2(1H)-one

3-Morpholino-1-(4-(2-oxopiperidin-1-yl)phenyl)-5,6-dihydropyridin-2(1H)-one synthesis

7synthesis methods

Product Name:3-Morpholino-1-(4-(2-oxopiperidin-1-yl)phenyl)-5,6-dihydropyridin-2(1H)-one
CAS Number:545445-44-1
Molecular formula:C20H25N3O3
Molecular Weight:355.43

3-Morpholino-1-(4-(2-oxopiperidin-1-yl)phenyl)-5,6-dihydropyridin-2(1H)-one can be used as pharmaceutical intermediates and is synthesized with 5-Chlorovaleroyl chloride and 1-(4-aminophenyl)-3-(morpholin-4-yl)-5,6-dihydropyridin-2(1H)-one.

4509-90-4 Synthesis

4509-90-4
227 suppliers
$15.00/1g

1267610-26-3 Synthesis

1-(4-AMinophenyl)-5,6-dihydro-3-(4-Morpholinyl)-2(1h)-pyridinone

1267610-26-3
236 suppliers
$40.00/5g

3-Morpholino-1-(4-(2-oxopiperidin-1-yl)phenyl)-5,6-dihydropyridin-2(1H)-one

545445-44-1
434 suppliers
$7.00/1g

Yield:545445-44-1 76%

Reaction Conditions:

Stage #1:5-bromovaleroyl chloride;1-(4-aminophenyl)-3-(morpholin-4-yl)-5,6-dihydropyridin-2(1H)-one with N-ethyl-N,N-diisopropylamine in tetrahydrofuran at 0 - 40; for 1 h;
Stage #2: with sodium hydride in ethyl acetate;tert-butyl alcohol at 10 - 40; for 3 h;Solvent;

Steps:

2 Preparation of Embodiment 4:3-morpholin-1 - [4 - (2-oxo-piperidinyl) phenyl] - 5,6-dihydro-pyridine -2 (1H)-one
General procedure: Room temperature, Compound 7 (5.8 g, 0.322 mmol), triethylamine 10. 6ml, tetrahydrofuran 176ml added to the reaction flask, stirring, cooling to 0 ° C, 5-chloropentanoyl chloride (5. 9g) Reaction lh; 0 ° C conditions, Sodium hydride (2 g, 0.083 mol) was added, Warm to Room temperature reaction 3h, The organic phase was washed with saturated brine once, dried over anhydrous magnesium sulfate, filtered and the solvent was evaporated to give a pale yellow solid. 15.3 g, nil Water ethanol recrystallization was a white solid, after drying 8. 2g, 0.023mol. Yield 72%, m.p. 202-204 ° C. HPLC: 99. 47% (instrument: Waters high performance liquid chromatography, column: C18, column length: 25 cm, mobile phase: water: Flow rate: l.Oml / min, wavelength: 254nm, column temperature: 30 ° C, injection volume: 10μ1) 1st step acidylated, cyclization reaction feeding compound 3 (5.35g, 0 . 06mol), diisopropylethylamine (18 ml), 5-bromo toluene (15g, 0.07mol), tert- butylacohol armor (16.8g, 0 . 15mol), ethyl acetate as solvent, getting white solid, heavy after drying 8.5 g. The yield is 76%, melting point 99-100°C. The embodiment of the remaining step is repeated 1 operation, prepare compound 2. The embodiment of the identification data for the 1 same in.

References:

Shanghai Institute of Pharmaceutical Industry;China State Institute of Pharmaceutical Industry;Huo, Shaowei;Guo, Yekun;Zhong, Jingfen;Shi, Huilin CN103626689, 2016, B Location in patent:Paragraph 0033; 0054-0056; 0059

1575-61-7 Synthesis